TOPFUND WHERE YOUR MONEY GROWS
Home / Stocks / Laxmi Dental Limited
LAXMIDENTL

Laxmi Dental Limited Share Price

Live price, chart and which mutual funds hold this stock

TopFund Score: 56/100 · Average See breakdown ↓
…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 25 Sep 2026

₹199.07

Change

+2.02 (1.03%)

Open

₹197.05

Prev. Close

₹197.05

Day High

₹200.84

Day Low

₹196.02

Volume Analysis

Traded

64,495

Delivered

37,289

Delivery %

57.82%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (0)

No signal for this stock

Opportunities (1)

  • •Strong 3-year revenue growth (19.7%)

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹206.08 ₹203.46 ₹201.26 ₹198.64 ₹196.44 ₹193.82 ₹191.62
Fibonacci ₹203.46 ₹201.62 ₹200.48 ₹198.64 ₹196.8 ₹195.66 ₹193.82
Camarilla ₹200.4 ₹199.95 ₹199.51 ₹198.64 ₹198.63 ₹198.19 ₹197.74

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-27.55%

1 Week

+2.14%

1 Month

-0.36%

3 Months

-11.54%

6 Months

+12.17%

1 Year

-37.18%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹72.48

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

12.39%

Net margin 10.8% × asset turnover 0.94x × equity multiplier 1.22x

Company Overview

Sector

Healthcare

Market Cap

₹1,097 Cr

P/E (TTM)

31.6

ROE

14.8%

Book Value

₹44.3

Face Value

₹2.0

Source: Screener.in (Consolidated figures) — data as of 25 Sep 2026. Not investment advice.

TopFund Analysis

Laxmi Dental Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 56/100. The strongest factor is Financial Strength (100/100), while Cash Flow (0/100) is the weakest area to weigh before deciding. FII holding has been falling.

TopFund Score — Fundamentals Quality

56/100 — Average

Data confidence: 76/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 27 Sep 2026 · How we calculate this →

Financial Strength

100

Growth

99

Valuation

38

Cash Flow

0

Corporate Governance

56

Momentum

23

Institutional Ownership

42

Business Quality

67

Risk & Volatility

40

Liquidity

40

From Screener.in

  • +Company has reduced debt.
  • +Company is almost debt free.
  • +Company has delivered good profit growth of 103% CAGR over last 5 years
  • −Though the company is reporting repeated profits, it is not paying out dividend
  • −Tax rate seems low
  • −Working capital days have increased from 72.9 days to 182 days

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Shareholder Meeting / Postal Ballot-Outcome of AGM 25 Sep

22nd AGM held on 25 Sep 2026; resolutions included financial statement adoption, director reappointment, and IPO proceeds timeline extension.

Closure of Trading Window 25 Sep

Trading window closed from October 1, 2026 until 48 hours after Q2 FY27 results.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 23 Sep

Intimation of Schedule of Analyst/ Institutional Investor meetings under the SEBI (LODR), Regulations 2015 to be held on 29th September, 2026.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 23 Sep

Intimation of Schedule of Analyst/ Institutional Investor meetings under the SEBI (LODR), Regulations 2015 to be held on 28th September, 2026.

Intimation Of Approval For Listing And Trading Of Further Issue Of Equity Shares Under Laxmi Dental Employee Stock Option Scheme 2024 18 Sep

NSE and BSE approved listing and trading of 7,911 ESOP shares from September 18, 2026.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Sales + 48 55 60 57 62 61 66 72 66 74 75
Expenses + 44 43 46 48 52 51 54 61 59 60 60
Operating Profit 4 12 14 9 10 10 12 11 7 14 14
OPM % 8.0% 21.0% 23.0% 15.0% 16.0% 16.0% 18.0% 15.0% 11.0% 18.0% 19.0%
Other Income + 0 0 6 1 1 2 2 2 -4 2 2
Interest 1 1 1 1 2 1 0 0 0 0 0
Depreciation 3 3 3 3 4 4 4 4 4 4 4
Profit before tax -1 7 16 5 5 6 10 9 -1 11 12
Tax % -140.0% 16.0% 11.0% 23.0% 23.0% 41.0% 24.0% 20.0% -175.0% 4.0% 21.0%
Net Profit + 2 8 17 6 5 4 8 9 2 10 10
EPS in Rs 74 244 6 2 1 1 2 2 0 2 2
Raw PDF — — — — — — — — — — —

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 150 92 137 162 194 239 278 287
Expenses + 146 88 130 152 169 196 234 241
Operating Profit 3 4 7 9 24 43 44 46
OPM % 2.3% 4.6% 4.8% 6.0% 13.0% 18.0% 16.0% 16.0%
Other Income + 2 0 -10 2 0 10 3 3
Interest 3 3 4 4 6 6 2 1
Depreciation 7 6 8 11 12 15 16 17
Profit before tax -4 -4 -16 -5 7 31 29 31
Tax % 5.0% 8.0% 15.0% 4.0% -136.0% 21.0% 9.0% —
Net Profit + -5 -5 -19 -4 25 32 29 31
EPS in Rs -155 -156 -597 -129 805 6 5 6
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% —

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Reserves 37 33 9 6 31 198 232
Borrowings + 37 39 50 50 61 20 13
Other Liabilities + 31 34 43 40 46 60 40
Total Liabilities 106 106 103 97 139 288 297
Fixed Assets + 39 42 40 40 46 51 63
CWIP 0 7 0 0 0 0 0
Investments 0 0 0 0 6 10 27
Other Assets + 66 56 63 56 87 227 207
Total Assets 106 106 103 97 139 288 297
Equity Capital 0 0 0 0 0 11 11

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 12 10 -2 14 8 44 -5
Cash from Investing Activity + -18 -9 3 -10 -11 -29 -78
Cash from Financing Activity + 6 0 -4 -1 -3 111 -18
Net Cash Flow 0 0 -3 3 -5 125 -101
CFO/OP 357 226 -30 157 38 109 4
Free Cash Flow -5 0 0 5 -5 28 -23

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 41.7% → 41.8%
  Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Public 11.19% 10.39% 14.05% 15.01% 16.5% 17.21%
Promoters 41.7% 41.7% 41.7% 41.7% 41.77% 41.8%
FII 34.24% 33.59% 32.39% 32.45% 31.2% 30.1%
DII 12.86% 14.3% 11.85% 10.82% 10.52% 10.89%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Laxmi Dental Limited (this stock) 1,097 31.6 4.49 14.8%
Bharat Parenterals Ltd. 1,077 — 3.3 -2.54%
Themis Medicare Ltd. 1,077 624.0 2.7 0.41%
Sigachi Industries Ltd 1,125 50.0 2.16 5.78%
Lincoln Pharma Ltd 1,182 12.2 1.56 12.3%
3b Blackbio Dx Ltd. 1,207 21.7 3.72 19.8%
Shree Ganesh Remedies Ltd 946 61.2 5.8 10.8%

Which Mutual Funds Hold Laxmi Dental Limited?

Frequently Asked Questions about Laxmi Dental Limited

Community Sentiment

What are other investors saying about Laxmi Dental Limited?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.